A 2019 in vitro study had promising results, finding that CBP/p300 inhibition in bladder cancer cells led to decreased Myc expression, thereby increasing apoptosis and reducing the proliferation of malignant cells [67]. The gene discussed is CREBBP; the disease is urinary bladder carcinoma.